Directed biosynthesis of new celestosaminide-antibiotics by Streptomyces caelestis.
D000327:Adsorption; D000636:Aminosalicylic Acids / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000032:analysis / Q000096:biosynthesis* / Q000494:pharmacology; D002854:Chromatography, Paper; D002855:Chromatography, Thin Layer; D003377:Countercurrent Distribution; D005285:Fermentation; D005374:Filtration; D007475:Ion Exchange Resins; D009682:Magnetic Resonance Spectroscopy; D008826:Microbial Sensitivity Tests; D011759:Pyrrolidines / Q000032:analysis / Q000096:biosynthesis / Q000494:pharmacology; D013055:Spectrophotometry, Infrared; D013302:Streptomyces / Q000378:metabolism*; D013865:Thioglycosides / Q000032:analysis / Q000096:biosynthesis / Q000494:pharmacology
D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D007475:Ion Exchange Resins; D011759:Pyrrolidines; D013865:Thioglycosides